Long-term follow-up consistent with earlier report, a hint of benefit in high-grade diseas ...

ImmunityBio, Inc. receives a Strong Buy rating, driven by ANKTIVA's compelling clinical data and major regulatory catalysts ...

Deb Hipp is a freelance health and medical writer and editor who lives in Kansas City, Missouri. She is a former investigative reporter with more than 25 years of experience as a journalist and writer ...

The developer of a non-invasive blood-based assay, BCAL hopes to enter the US market by the quicker lab-developed test route.

Discover the top fitness gifts carefully selected and tested by our team. Explore finds from Hoka, Lululemon, BowFlex, Oddobody, and many more.

Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion, recommending ...

In an in-depth interview, Omar Nadeem, MD, explores the promising findings from 20 patients with smoldering myeloma treated with cilta-cel. For decades, patients with smoldering multiple myeloma have ...

Approval included two companion diagnostics defining HER2 positivity as IHC 3+ or ISH+ to select candidates for T-DXd. Neoadjuvant T-DXd×4 → THP×4 increased centrally assessed pCR over ddAC-THP (67.3% ...

Outcomes for patients with high-risk large B-cell lymphoma (LBCL), defined by an International Prognostic Index (IPI) score ...

ASCO Guidelines provide recommendations with comprehensive review and analyses of the relevant literature for each recommendation, following the guideline development process as outlined in the ASCO ...

In a study published in Science, researchers from The University of Texas MD Anderson Cancer Center have developed a spatial ...